Tawwab Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.79 M
as on 02-07-2024
- Paid Up Capital ₹ 2.70 M
as on 02-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.10 M
as on 02-07-2024
- Revenue 105.11%
(FY 2023)
- Profit 41.71%
(FY 2023)
- Ebitda 9.02%
(FY 2023)
- Net Worth 70.68%
(FY 2023)
- Total Assets 174.46%
(FY 2023)
About Tawwab Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.79 M and a paid-up capital of Rs 2.70 M.
The company currently has active open charges totaling ₹5.10 M.
Irfan Kazi and Mehjabeen Kazi serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC312223
- Company No.
312223
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tawwab Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Irfan Kazi  | Director | 25-Jul-2018 | Current |
| Mehjabeen Kazi | Director | 25-Jul-2018 | Current |
Financial Performance of Tawwab Pharma.
Tawwab Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 105.11% increase. The company also saw a substantial improvement in profitability, with a 41.71% increase in profit. The company's net worth Soared by an impressive increase of 70.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tawwab Pharma?
In 2023, Tawwab Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Jul 2022 | ₹5.10 M | Open |
How Many Employees Work at Tawwab Pharma?
Unlock and access historical data on people associated with Tawwab Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tawwab Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tawwab Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
